English EN Spanish ES French FR Chinese (Simplified) ZH-CN
Print Friendly, PDF & Email

NCT/Study#

NCT04166409 /

COG-ACNS1833

A Phase 3 Randomized Non-Inferiority Study Of Carboplatin And Vincristine Versus Selumetinib (NSC# 748727) In Actively Diagnosed Or Previously Untreated Low-Grade Glioma (LGG) Not Associated With BRAFV600E Mutations Or Systemic Neurofibromatosis Type 1 (NF1)

DISEASE GROUP:
Pediatric Oncology
current phase:
Phase III
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: